HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige beauty insight from NPD

This article was originally published in The Rose Sheet

Executive Summary

From January through September of this year, 29% of foundations were sold in compact form, 31% of those as a crème to powder formula, and 36% of foundations offer SPF protection, up 11% from the same period last year, according to new data from the NPD Group, released Nov. 23. The firm also found that 33% of all blushes are bronzers, and sales of bronzers are down 1% while general blush sales fell 5% in the first nine months of the year. Sales of palettes with five or more eye shadow shades grew 23% while the overall eye shadow category decreased 12%. Market research firm also has data on lip products/plumpers

You may also be interested in...



Cosmetic/Skin-Care Combinations Advised With Traditional Makeup Down

Use of makeup products among women ages 18 to 64 is down 5 percent from 2008, with women looking to simplify their beauty routines, according to a new study from the NPD Group

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel